我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

缺血/再灌注心肌к阿片受体的变化及其与抗I/R性心律失常的关系

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2009年第3期
页码:
317-320,328
栏目:
基础研究
出版日期:
2009-05-15

文章信息/Info

Title:
Changes of κ-opioid receptor in myocardium of rats with ischemia and reperfusion and its relationship with I/R
作者:
殷召1李红梅2郭海涛1张淑苗1肖安1张权宇1王跃民1裴建明1
1.第四军医大学基础部生理学教研室,陕西 西安 710032; 2.解放军323医院心内科,陕西 西安 710054)
Author(s):
YIN Zhao1 LI Hong-mei2 GUO Hai-tao1 ZHANG Shu-miao1 XIAO An1 ZHANG Quan-yu1 WANG Yue-min1 PEI Jian-ming1
1.Department of Physiology, Fourth Military Medical University, Xi’an 710032, Shaanxi, China; 2.Department of Cardiology, PLA 323rd Hospital, Xi’an 710054, Shaanxi, China
关键词:
缺血/再灌注κ阿片受体心律失常U50488Hnor-BNI
Keywords:
ischemia/reperfusion к-opioid receptor arrhythmia U50488H nor-BNI
分类号:
R331.3;R364.1
DOI:
-
文献标识码:
A
摘要:
目的 观察κ阿片受体(κ opioid receptor,κ-OR)在抗大鼠心肌缺血/再灌注(ischemia and reperfusion,I/R)中的变化及其与抗I/R性心律失常的关系。方法 将48只SD大鼠随机分为6组,每组8只,即对照组、U50,488H组、I/R组、U50,488H+I/R组、BNI+U50,488H+I/R组和BNI+I/R组,用于建立在体的大鼠I/R模型,观察κ-OR激动剂U50,488H对大鼠心肌I/R模型室性心律失常的影响。另取18只SD大鼠随机分为6组,每组3只,即对照组、假手术组、再灌注即刻组、60、180和360 min组,用于RT-PCR及Western blot检测I/R处理后心肌组织中κ-OR mRNA转录及其蛋白的表达。结果 对照组偶发早搏,I/R组心律失常的发生率明显增加(P<0.01)。给予U50,488H可以明显降低I/R引起的室速和室颤的发生率(P<0.01)及心律失常的评分(P<0.05)。U50,488H抗心律失常的作用可被选择性的κ-OR拮抗剂nor-BNI完全阻断(P<0.01),而nor-BNI本身对I/R所致心律失常没有影响。RT-PCR的结果发现,κ-OR mRNA的转录水平在再灌注的即刻、再灌注后60及180 min时,明显高于对照组(P<0.01),在60 min时达到高峰,360 min时恢复到正常水平。Western blot检测表明,在再灌注的即刻、再灌注后60,180 和360 min时,κ-OR蛋白的表达量均明显高于对照组(P<0.05)。结论 在心肌I/R时,κ-OR基因的转录和其蛋白表达的水平明显上调,可能与其抗I/R性心律失常的作用相关。
Abstract:
AIM To investigate the anti-arrhythmic effect of к-opioid receptor (κ-OR) and its changes during myocardial ischemia and reperfusion (I/R). METHODS Forty-eight Sprague- Dawley rats were randomly divided into 6 groups with 8 rats in each group: ①Control group, ②Control+U50,488H group, ③I/R group, ④U50,488H+I/R group, ⑤U50,488H+nor-BNI+I/R group, and ⑥nor-BNI+I/R group. This protocol was used to set up the animal model of myocardial I/R and investigate the effect on ventricular arrhythmic of κ-OR agonist, U50,488H, during I/R. Other Eighteen Sprague-Dawley rats were randomly divided into 6 groups with 3 rats in each group: ①Control group, ②Sham operation group, ③I/R 0 min group, ④I/R 60 min group, ⑤I/R 180 min group, and ⑥I/R 360 min group. This protocol was used to investigate the levels of к-OR mRNA and its protein in rats heart at different time points during I/R by RT-PCR and Western blot, respectively. RESULTS Few ventricular premature contractions were observed in control group and the incidence of arrhythmia in I/R group significantly increased (P<0.01). With pretreatment of U50,488H, the incidence of ventricular tachycardia and ventricular fibrillation (P<0.01) was reduced as well as arrhythmia score in I/R group (P<0.05). With pretreatment of selective κ-OR antagonist (nor-BNI), the anti-arrhythmic effect of U50,488H was completely blocked (P<0.01). But it had no effect on the arrhythmia induced by I/R(P>0.05). Compared with those in control group, the levels of κ-OR mRNA was significantly increased at 0 min, 60 min and 180 min during reperfusion (P<0.01) and increased to utmost amount at 60 min, but decreased to the normal level at 360 min; compared with those in control group, the density of κ-OR protein increased significantly at 0min, 60min, 180min and 360min during reperfusion (P<0.05). CONCLUSION During myocardial I/R, the transcription of κ-OR mRNA and the expression of its protein are increased, which may be related to the anti-arrhythmia effect during myocardial I/R.

参考文献/References

[1] Cheng L, Ma S, Wei LX, et al. Cardioprotective and antiarrhythmic effect of U50,488H in ischemia/reperfusion rat heart[J]. Heart Vessels, 2007, 22(5):335-344.

[2] Fang X, Tang W, Sun S, et al. delta-Opioid-induced pharmacologic myocardial hibernation during cardiopulmonary resuscitation[J]. Crit Care Med, 2006, 34(12 Suppl):S486-S489.

[3] Tai KK, Jin WQ, Chan TK, et al. Characterization of [3H]U69593 binding sites in the rat heart by receptor binding assays[J]. J Mol Cell Cardiol, 1991, 23(11):1297-1302.

[4] Giros B, Pohl M, Rochelle JM, et al. Chromosomal localization of opioid peptide and receptor genes in the mouse[J]. Life Sci, 1995, 56(18):PL369-PL375.

[5] Walker MJ, Curtis MJ, Hearse DJ, et al. The Lambeth conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion[J]. Cardiovasc Res, 1988, 22(7):447-455.

[6] 张鹏,朱运龙,王跃民,等. к-阿片受体选择性激动剂U50,488H对大鼠心肌缺血/再灌注室性心律失常的影响[J]. 第四军医大学学报, 2004, 25(18):1648-1651.

[7] 姚青,王跃民,张鹏,等. к-阿片受体介导的抗心律失常作用[J]. 心脏杂志, 2004, 16(2):109-112.

[8] 马赛,马骏雄,吕顺艳,等. 阿片肽对心律失常的影响及机制[J]. 中国实用医学研究杂志, 2005, 4(2):174-177.

[9] Peart JN, Gross ER, Gross GJ. Effect of exogenous kappa opioid receptor activation in rat model of myocardial infarction[J]. J Cardiovasc Pharmacol, 2004, 43(3):410-415.

[10]Boutin H, Catherine A, Mackenzie ET, et al. Long-term alterations in mu, delta and kappa opioidergic receptors following middle cerebral artery occlusion in mice[J]. Acta Neuropathol, 2007, 114(4):491-500.

备注/Memo

备注/Memo:
收稿日期:2007-10-21.基金项目:国家自然科学基金面上项目资助(30770802及30370580)及全军医药卫生科研基金军队“十一五”计划面上项目资助(06MA203) 通讯作者:裴建明,教授,主要从事心脏内分泌的研究Email:Jmpei8@fmmu.edu.cn 作者简介:殷召,本科生Email:yinzhaofmmu@163.com
更新日期/Last Update: 2009-05-18